Fate Therapeutics
Price & Volume
Stats
See more52W Range | $0.91-$3.21 |
Market Cap | $352M |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $6.3M |
Revenue Growth (YoY) | -20.3% |
Gross Profit (12 Mos) | -$81.1M |
Diluted EPS | -$1.10 |
News
See moreYahoo Finance • 3 days ago
Fate Therapeutics to Present Preliminary Clinical Data of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Sclerosis at the ISSCR 2026 Annual Meeting
Yahoo Finance • 6 days ago
Strong Buy at under $10: The highest Quant-rated bargain stocks right now
Yahoo Finance • 12 days ago
Health Care had the best week vs. the S&P 500 on record
Yahoo Finance • 24 days ago
Fate Therapeutics Appoints Laura Hamill to Board of Directors
About
CEO | Dr. Bahram Valamehr M.B.A., Ph.D. |
CFO | Mr. Kamal Adawi M.S., MBA |
Address | 12278 Scripps Summit Drive, San Diego, CA, United States, 92131 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 161 |